Yahoo

FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk
Explore stocks on Coinbase

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

The U.S. Food and Drug Administration (FDA) on Tuesday issued a warning letter to Fresenius Medical Care AG & Co. KGaA'sFresenius USA Manufacturing following a March 2026 inspection at its Ogden, Utah production facility.

In a letter to the company's CEO, Helen Giza, Federal regulators determined that the plant committed major Current Good Manufacturing Practice violations, rendering its finished pharmaceutical products adulterated under the Federal Food, Drug, and Cosmetic Act.

Unchecked Dialysis Solution Leaks

FDA investigators found that the facility failed to thoroughly investigate customer complaints involving leaking bags of Delflex Peritoneal Dialysis Solution.

Don't Miss:

The plant received 35 complaints covering 156 leaking units linked to printing defects.

Although internal risk protocols classify peritonitis as a severe hazard, the firm improperly categorized the defect as low-severity property damage and avoided immediate recalls.

The company eventually issued voluntary recalls in April 2026 after the federal inspection.

Regulators emphasized that non-sterile solutions expose patients to life-threatening infection risks, especially since dextrose in the solution accelerates microbial growth.

Deficiencies In Visual Inspection Programs

The agency also cited the facility for failing to establish adequate written procedures for process controls.

The plant's visual inspection program failed to verify that sterile injectable products remained free of visible particles.

Trending: Avoid the #1 Investing Mistake: How Your 'Safe' Holdings Could Be Costing You Big Time

Inspector qualification kits lacked representative particulate sizes, missing the critical 100-to-150 micron range required to adequately challenge staff detection capabilities.

Fresenius Requires Consultant Audits And Federal Enforcement

The FDA advised the company to retain an independent expert to perform a full six-system audit and overhaul its quality unit oversight.

The facility must submit comprehensive remediation plans addressing process capability, root cause analyses, and manufacturing line controls.

Regulators warned that failing to address these compliance failures promptly could trigger enforcement actions, including product seizures, court injunctions, and the withholding of export certificates or new drug approvals.

Photo by Tada Images via Shutterstock

Read Next: 

Building Wealth Across More Than Just the Market

Building a resilient portfolio means thinking beyond a single asset or market trend. Economic cycles shift, sectors rise and fall, and no one investment performs well in every environment. That's why many investors look to diversify with platforms that provide access to real estate, fixed-income opportunities, precious metals, and even self-directed retirement accounts. By spreading exposure across multiple asset classes, it becomes easier to manage risk, capture steady returns, and create long-term wealth that isn't tied to the fortunes of just one company or industry.

Arrived

Backed by Jeff Bezos, Arrived Homes makes real estate investing accessible with a low barrier to entry. Investors can buy fractional shares of single-family rentals and vacation homes starting with as little as $100 . This allows everyday investors to diversify into real estate, collect rental income, and build long-term wealth without needing to manage properties directly.

Qnetic

As electricity demand rises alongside AI, data centers, and renewable energy, long-duration energy storage is becoming increasingly important. Qnetic is developing a kinetic energy storage system designed to provide long-lasting, chemical-free electricity storage , offering investors exposure to the infrastructure supporting a more resilient and reliable power grid.

EquityMultiple

For accredited investors looking beyond stocks and bonds, EquityMultiple provides access to vetted commercial real estate deals starting at $5,000 , with only ~5% of opportunities passing their due diligence process. 

FarmTogether

Farmland has historically held its value through market volatility and delivered returns uncorrelated to stocks and bonds. For accredited investors, FarmTogether offers direct access to high-quality U.S. farmland starting at $15,000 — fully managed, with no landlord headaches.

Fundrise

Private real estate and private credit can add income and stability to a stock-heavy portfolio. Fundrise offers access to diversified private real estate and credit strategies through an easy-to-use platform, with professionally managed portfolios designed to generate passive income and long-term growth.

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Mobilize your Website
View Site in Mobile | Classic
Share by: